Entries by april@madhedgefundtrader.com

April 16, 2025

Mad Hedge Technology Letter April 16, 2025 Fiat Lux   Featured Trade: (AMERICAN TECH ABLE TO OUTFLANK) (NVDA), (TSM), (AAPL)

American Tech Able To Outflank

I understand that the U.S. administration wants to bring back American manufacturing, but that will not include Silicon Valley manufacturing. There is a higher likelihood that if China is a no-go zone, American tech companies will venture out to a low-tariff, cheap labor country to continue their path to profits. If you look through the

April 16, 2025

  (SURVIVING THE TARIFFIED WORLD)   April 16, 2025   Hello everyone   The global economic landscape is being reshaped as we speak.  There are now heightened concerns about economic growth, currency stability, and financial retaliation.  We need to consider China’s potential response via US Treasury yields and other retaliatory measures. On April 2, 2025,

Trade Alert - (PLTR) April 16, 2025 - BUY

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.

Trade Alert - (NFLX) April 17, 2025 - EXPIRATION AT MAX PROFIT

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.

April 15, 2025

Mad Hedge Biotech and Healthcare Letter April 15, 2025 Fiat Lux   Featured Trade: (THE WEIGHT OF EXPECTATIONS) (LLY), (NVO)

The Weight Of Expectations

You know that feeling when you've found the perfect restaurant? The food is exquisite, the atmosphere divine, and then you get the bill—and suddenly you're calculating if selling a kidney is a viable financial strategy. That's essentially my relationship with Eli Lilly (LLY) right now. Phenomenal company, stellar performance, price tag that makes my wallet

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.